PAZEO

Google image searchProduct monograph

Active ingredient

olopatadine (olopatadine hydrochloride), 0.7 %/W/V

DIN: 02458551

Dosage form(s): SOLUTION

Route(s) of administration: OPHTHALMIC

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 12-MAR-2018

ATC:

• S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
• S01G — DECONGESTANTS AND ANTIALLERGICS (ATC, ATC/DDD)
• S01GX — Other antiallergics (ATC, ATC/DDD)
• S01GX09 — OLOPATADINE (ATC/DDD)

Reference brand drug: Pataday, Patanol

Pharmaceutical standard: MFR

External Links for Pazeo

Search on Google

• Pazeo side effects
• Pazeo dosage
• olopatadine side effects
• olopatadine dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find pazeo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.